Keyword Suggestion
Domain Informations
Tagrisso.com lookup results from whois.comlaude.com server:
- Domain created: 2015-04-24T18:14:28Z
- Domain updated: 2026-03-25T23:05:41Z
- Domain expires: 2027-04-24T18:14:28Z 0 Years, 305 Days left
- Website age: 11 Years, 59 Days
- Registrar Domain ID: 1922954420_DOMAIN_COM-VRSN
- Registrar Url: http://www.comlaude.com
- Registrar WHOIS Server: whois.comlaude.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +442074218250
- Name server:
- NS-1077.AWSDNS-06.ORG
- NS-1818.AWSDNS-35.CO.UK
- NS-720.AWSDNS-26.NET
- NS-98.AWSDNS-12.COM
Network
- inetnum : 52.84.0.0 - 52.85.255.255
- name : AMAZO-CF
- handle : NET-52-84-0-0-2
- status : Reallocated
- created : 1995-01-23
- changed : 2022-09-30
- desc : -----BEGIN CERTIFICATE-----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-----END CERTIFICATE-----
Owner
- organization : Amazon.com, Inc.
- handle : AMAZON-4
- address : Array,SEATTLE,WA,98101-1244,US
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 52.85.31.26
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Timezone: America/Los_Angeles
Site Inspections
Port Scanner (IP: 52.85.31.26)
Spam Check (IP: 52.85.31.26)
Recent Searched Sites
› Frenzyevents.com (1 seconds ago) / US
› Baking4happiness.com (19 seconds ago) / US
› Piwo-neptun.pl (7 seconds ago) / PL
› Fao.eyedro.com (1 seconds ago) / US
› Luxuryland.sa (3 seconds ago) / CA
› Click.namaidani.com (9 seconds ago) / UA
› Top.domains (11 seconds ago) / GB
› Tagrisso.com (1 seconds ago) / US
› Sunpuresuperfoods.com.au (6 seconds ago) / CA
› Remitly.se (1 seconds ago) / US
› Trauststructured.com (4 seconds ago) / CA
› Aprisorx.com (1 seconds ago) / SE
› Hosang-consulting.com (1 seconds ago) / US
› Yotsuike-sports.com (0 seconds ago) / US
› Stlthgrp.com (8 seconds ago) / US
› Cougarhacks2025.devpost.com (2 seconds ago) / US
› Phmg.com (4 seconds ago) / US
› Drccu.com (9 seconds ago) / US
› My.perrytech.edu (7 seconds ago) / US
› Purchasing.beis.com (1 seconds ago) / US
Websites Listing
We found Websites Listing below when search with tagrisso.com on Search Engine
Contact Us – TAGRISSO® (osimertinib)
If you would like more information about TAGRISSO®(osimertinib) or any other AstraZeneca products, please contact the information center in the US at 1-800-236-9933. Important Safety Information; Prescribing Information; For Healthcare Professionals; Sign Up for Support; Contact us. If you would like additional information regarding AstraZeneca products, please contact the …
Tagrisso.comlanding-page
This website is intended to provide information about TAGRISSO for Canadian healthcare providers (HCPs) and patients who are prescribed TAGRISSO. I am a Canadian HCP I am a Canadian patient prescribed TAGRISSO You are now leaving Tagrisso.ca . You have selected a link that will take you to a site maintained by a third party who is solely responsible for its …
Tagrisso.caContact – Tagrisso Connect
Please note that AstraZeneca UK must verify your contact details against our healthcare professional contact information database. If your contact details are available within this database, an AstraZeneca UK colleague will send you an email to allow you to confirm your opt-in status to receiving future emails. If your contact details are not ...
Tagrissoconnect.co.ukTagrisso | Healthing.ca
Enter your email Sign Up By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails.
Healthing.caANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - Europa
TAGRISSO can be taken with or without food at the same time each day. Dose adjustments Dosing interruption and/or dose reduction may be required based on individual safety and tolerability. If dose reduction is necessary, then the dose should be reduced to 40mg taken once daily. Dose reduction guidelines for adverse reactions toxicities are provided in Table 1. Table …
Ema.europa.euDosing & Dose Management – TAGRISSO® (osimertinib)
Dose Management 1. Disperse tablet in 60 mL (2 ounces) of noncarbonated water only. Stir until tablet is dispersed into small pieces (the tablet will not completely dissolve), and swallow immediately. Do not crush, heat, or ultrasonicate during preparation. Rinse the container with 120 mL to 240 mL (4 to 8 ounces) of water and immediately drink.
Tagrissohcp.comPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …
TAGRISSO has not been established in patients with end-stage renal disease [Creatinine clearance (CLcr) less than 15mL/min, calculated by the Cockcroft and Gault equation], or on dialysis.Caution . TAGRISSO® (osimertinib) Product Monograph. COPYRIGHT 2016-2022ASTRAZENECA CANADA INC. Page 6 of 62 should be exercised when treating patients …
Astrazeneca.caSee posts, photos and more on Facebook.
Facebook.comwww.tagrissosavings.com
Www.tagrissosavings.com
Tagrissosavings.comTAGRISSO® (osimertinib) HCP - Home - Facebook
2018-08-06 · TAGRISSO® (osimertinib) HCP. 876 likes · 10 talking about this. Please see full Important Safety Information below under "Safety Information" and at tagrissohcp.az/homeFB This product information is...
Facebook.comTagrisso | Benzinga
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Benzinga.comTAGRISSO - Haute Autorité de Santé
2020-03-20 · TAGRISSO 40 mg, comprimés pelliculés 30 plaquettes aluminium de 1 comprimé (CIP : 34009 300 476 4 4) TAGRISSO 80 mg, comprimés pelliculés 30 plaquettes aluminium de 1 comprimé (CIP : 34009 300 476 5 1) Recherche Menu principal Contenu principal. Industriels Fermer. Professionnels; Établissements et services; Usagers; Industriels (élément …
Has-sante.frTagrisso (Osimertinib) 80mg tablets Price, Uses, Side Effects
The side effects of Tagrisso (Osimertinib) tablets are anemia, low white blood cells, diarrhea, chest pain, shortness of breath, trouble concentrating, dizziness, headache, skin rash, allergic reactions, dry skin, etc. Q4. What happens if I overdose on Tagrisso (Osimertinib)?
Globanspharma.comTagrisso - opinie, wskazania, działanie, dawkowanie
Tagrisso - - Dowiedz się jak stosować Tagrisso i jakie jest zalecane dawkowanie. Na stronie m.in. opis działania, wskazania, skład, zamienniki oraz opinie pacjentów. Lek TAGRISSO zawiera substancję czynną ozymertynib, która należy do klasy inhibitorów kinaz białkowych leków przeciwnowotworowych. Lek TAGRISSO jest
Baza-lekow.com.plTagrisso (Osimertinib) Market Product Type 40 mg,80 mg Sales, …
2022-05-10 · The global Tagrisso (Osimertinib) market size is projected to reach multi million by 2028, in comparision to 2021, at unexpected CAGR during 2022-2028 (Ask for Sample Report).
Marketwatch.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| hsgroup.com | registrar.amazon.com | 193 Days |
| moderndaymedspa.com | godaddy.com | -1 Years, -136 Days |
| watakazu.com | gmo.jp | -4 Years, -27 Days |
| crashmasters.com | gkg.net | -3 Years, -161 Days |
| ranonline-bakbakan.com | crazydomains.com.au | -3 Years, -235 Days |
| gearstips.com | namecheap.com | -4 Years, -94 Days |
| fushiwellbeing.com | paragonnames.com | -2 Years, -13 Days |
| theydo.com | key-systems.net | -3 Years, -173 Days |
| genat.org | tucows.com | 6 Years, 210 Days |
| 9iao.com | ename.net | -4 Years, -21 Days |